Paladin Labs acquires Canadian rights to Tempra children’s pain relief products
MONTREAL – Pharmaceutical company Paladin Labs Inc. has acquired the Canadian rights to the Tempra children’s pain relief products from Bristol Myers Squibb.

Read more on The Canadian Press via Yahoo! Canada News

Related Posts: